{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:44:49Z","timestamp":1791305089229,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1743-422x-11-172","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T17:01:35Z","timestamp":1412096495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM\/TSP"],"prefix":"10.1186","volume":"11","author":[{"given":"Heather A","family":"Niederer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Laydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjet","family":"Elemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becca","family":"Asquith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles RM","family":"Bangham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"key":"2499_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O: Epidemiological Aspects and World Distribution of HTLV-1 Infection. Front Microbiol 2012, 3: 388.","journal-title":"Front Microbiol"},{"key":"2499_CR2","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","volume":"120","author":"LB Cook","year":"2012","unstructured":"Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CRM: HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 2012, 120: 3488-3490. 10.1182\/blood-2012-07-445593","journal-title":"Blood"},{"key":"2499_CR3","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","volume":"112","author":"J Arnold","year":"2008","unstructured":"Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL: Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008, 112: 3788-3797. 10.1182\/blood-2008-04-154286","journal-title":"Blood"},{"key":"2499_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.0507631103","volume":"103","author":"Y Satou","year":"2006","unstructured":"Satou Y, Yasunaga J-i, Yoshida M, Matsuoka M: HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci 2006, 103: 720-725. 10.1073\/pnas.0507631103","journal-title":"Proc Natl Acad Sci"},{"key":"2499_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/sj.bjc.6605345","volume":"101","author":"M Boxus","year":"2009","unstructured":"Boxus M, Willems L: Mechanisms of HTLV-1 persistence and transformation. Br J Cancer 2009, 101: 1497-1501. 10.1038\/sj.bjc.6605345","journal-title":"Br J Cancer"},{"key":"2499_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmicb.2012.00389","volume":"3","author":"Y Yamano","year":"2012","unstructured":"Yamano Y, Sato T: Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy\/tropical spastic paraparesis. Front Microbiol 2012, 3: 389.","journal-title":"Front Microbiol"},{"key":"2499_CR7","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N: Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol 1998, 4: 586-593. 10.3109\/13550289809114225","journal-title":"J Neurovirol"},{"key":"2499_CR8","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/eji.200939451","volume":"39","author":"CRM Bangham","year":"2009","unstructured":"Bangham CRM: CTL quality and the control of human retroviral infections. Eur J Immunol 2009, 39: 1700-1712. 10.1002\/eji.200939451","journal-title":"Eur J Immunol"},{"key":"2499_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/v3081374","volume":"3","author":"C Journo","year":"2011","unstructured":"Journo C, Mahieux R: HTLV-1 and innate immunity. Viruses 2011, 3: 1374-1394. 10.3390\/v3081374","journal-title":"Viruses"},{"key":"2499_CR10","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR: HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 1999, 96: 3848-3853. 10.1073\/pnas.96.7.3848","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2499_CR11","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1086\/420832","volume":"189","author":"PKC Goon","year":"2004","unstructured":"Goon PKC, Biancardi A, Fast N, Igakura T, Hanon E, Mosley AJ, Asquith B, Gould KG, Marshall S, Taylor GP, Bangham CRM: Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Diseases 2004, 189: 2294-2298. 10.1086\/420832","journal-title":"J Infect Diseases"},{"key":"2499_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/intimm\/3.8.761","volume":"3","author":"M Kannagi","year":"1991","unstructured":"Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M: Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 1991, 3: 761-767. 10.1093\/intimm\/3.8.761","journal-title":"Int Immunol"},{"key":"2499_CR13","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1128\/jvi.69.4.2649-2653.1995","volume":"69","author":"S Niewiesk","year":"1995","unstructured":"Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S, Bangham CR: Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol 1995, 69: 2649-2653.","journal-title":"J Virol"},{"key":"2499_CR14","doi-asserted-by":"publisher","first-page":"9389","DOI":"10.1128\/JVI.76.18.9389-9397.2002","volume":"76","author":"T Koiwa","year":"2002","unstructured":"Koiwa T, Hamano-usami A, Ishida T, Okayama A, Yamaguchi K, Kamihira S, Koiwa T, Hamano-usami A, Ishida T, Okayama A, Yamaguchi K, Kamihira S, Watanabe T: 5\u2032-Long Terminal Repeat-Selective CpG Methylation of Latent Human T-Cell Leukemia Virus Type 1 Provirus In Vitro and In Vivo. J Virol 2002, 76: 9389-9397. 10.1128\/JVI.76.18.9389-9397.2002","journal-title":"J Virol"},{"key":"2499_CR15","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065","volume":"88","author":"S Tamiya","year":"1996","unstructured":"Tamiya S, Matsuoka M, Etoh K, Watanabe T, Kamihira S, Yamaguchi K, Takatsuki K: Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood 1996, 88: 3065-3073.","journal-title":"Blood"},{"key":"2499_CR16","volume-title":"Blood","author":"LB Cook","year":"2014","unstructured":"Cook LB, Melamed A, Niederer H, Valganon M, Laydon D, Foroni L, Taylor GP, Matsuoka M, Bangham CRM: The role of HTLV-1 clonality, proviral structure and genomic integration site in adult T cell leukemia\/lymphoma. Blood 2014. doi:10.1182\/blood-2014-02-553602"},{"key":"2499_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1182\/blood.V97.4.987","volume":"97","author":"Y Furukawa","year":"2001","unstructured":"Furukawa Y, Kubota R, Tara M, Izumo S, Osame M: Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood 2001, 97: 987-993. 10.1182\/blood.V97.4.987","journal-title":"Blood"},{"key":"2499_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1099\/vir.0.80766-0","volume":"86","author":"B Asquith","year":"2005","unstructured":"Asquith B, Mosley AJ, Barfield A, Marshall SEF, Heaps A, Goon P, Hanon E, Tanaka Y, Taylor GP, Bangham CRM: A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. The Journal of General Virology 2005, 86: 1515-1523. 10.1099\/vir.0.80766-0","journal-title":"The Journal of General Virology"},{"key":"2499_CR19","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1182\/blood-2008-02-140335","volume":"112","author":"AH Sabouri","year":"2008","unstructured":"Sabouri AH, Usuku K, Hayashi D, Izumo S, Ohara Y, Osame M, Saito M: Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. Blood 2008, 112: 2411-2420. 10.1182\/blood-2008-02-140335","journal-title":"Blood"},{"key":"2499_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J-I, Saito K, Arimura K, Matsuoka M, Ohara Y: In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology 2009, 6: 19. 10.1186\/1742-4690-6-19","journal-title":"Retrovirology"},{"key":"2499_CR21","doi-asserted-by":"publisher","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001117","volume":"6","author":"A Macnamara","year":"2010","unstructured":"Macnamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K, Yasukawa M, Taylor G, Bangham CRM, Asquith B: HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog 2010, 6: e1001117. 10.1371\/journal.ppat.1001117","journal-title":"PLoS Pathog"},{"key":"2499_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/molbev\/msh053","volume":"21","author":"S Van Dooren","year":"2004","unstructured":"Van Dooren S, Pybus OG, Salemi M, Liu H-F, Goubau P, Remondegui C, Talarmin A, Gotuzzo E, Alcantara LCJ, Galv\u00e3o-Castro B, Vandamme A-M: The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains. Mol Biol Evol 2004, 21: 603-611.","journal-title":"Mol Biol Evol"},{"key":"2499_CR23","doi-asserted-by":"publisher","first-page":"e1003271","DOI":"10.1371\/journal.ppat.1003271","volume":"9","author":"A Melamed","year":"2013","unstructured":"Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CRM: Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog 2013, 9: e1003271. 10.1371\/journal.ppat.1003271","journal-title":"PLoS Pathog"},{"key":"2499_CR24","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"NA Gillet","year":"2011","unstructured":"Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, Berry C, Bushman FD, Taylor GP, Bangham CRM: The host genomic environment of the provirus determines the abundance of HTLV-1-infected T cell clones. Blood 2011, 117: 3113-3122. 10.1182\/blood-2010-10-312926","journal-title":"Blood"},{"key":"2499_CR25","doi-asserted-by":"publisher","first-page":"e1003646","DOI":"10.1371\/journal.pcbi.1003646","volume":"10","author":"DJ Laydon","year":"2014","unstructured":"Laydon DJ, Melamed A, Sim A, Gillet NA, Sim K, Darko S, Kroll JS, Douek DC, Price DA, Bangham CRM, Asquith B: Quantification of HTLV-1 clonality and TCR diversity. PLoS Comput Biol 2014, 10: e1003646. 10.1371\/journal.pcbi.1003646","journal-title":"PLoS Comput Biol"},{"key":"2499_CR26","doi-asserted-by":"publisher","first-page":"e1000027","DOI":"10.1371\/journal.ppat.1000027","volume":"4","author":"KN Meekings","year":"2008","unstructured":"Meekings KN, Leipzig J, Bushman FD, Taylor GP, Bangham CRM: HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM\/TSP. PLoS Pathog 2008, 4: e1000027. 10.1371\/journal.ppat.1000027","journal-title":"PLoS Pathog"},{"key":"2499_CR27","doi-asserted-by":"publisher","first-page":"e1003687","DOI":"10.1371\/journal.ppat.1003687","volume":"9","author":"NA Gillet","year":"2013","unstructured":"Gillet NA, Guti\u00e9rrez G, Rodriguez SM, de Brogniez A, Renotte N, Alvarez I, Trono K, Willems L: Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog 2013, 9: e1003687. 10.1371\/journal.ppat.1003687","journal-title":"PLoS Pathog"},{"key":"2499_CR28","doi-asserted-by":"publisher","first-page":"e1003263","DOI":"10.1371\/journal.ppat.1003263","volume":"9","author":"NA Gillet","year":"2013","unstructured":"Gillet NA, Cook L, Laydon DJ, Hlela C, Verdonck K, Alvarez C, Gotuzzo E, Clark D, Farre L, Bittencourt A, Asquith B, Taylor GP, Bangham CRM: Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. PLoS Pathog 2013, 9: e1003263. 10.1371\/journal.ppat.1003263","journal-title":"PLoS Pathog"},{"key":"2499_CR29","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1073\/pnas.87.13.5218","volume":"87","author":"CL Tendler","year":"1990","unstructured":"Tendler CL, Greenberg SJ, Blattner W, Manns A, Murphy E, Fleisher T, Hanchard B, Morgan O, Burton JD, Nelson DL: Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci U S A 1990, 87: 5218-5222. 10.1073\/pnas.87.13.5218","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2499_CR30","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1089\/08892220050193209","volume":"16","author":"N Azimi","year":"2000","unstructured":"Azimi N, Mariner J, Jacobson S, Waldmann TA: How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy\/tropical spastic paraparesis? AIDS Res Hum Retroviruses 2000, 16: 1717-1722. 10.1089\/08892220050193209","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2499_CR31","first-page":"1096","volume":"3","author":"JEOM Kaplan","year":"1990","unstructured":"Kaplan JEOM, Kubota H, Igata A, Nishitani H, Maeda Y, Khabbaz RF, Janssen RS: The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990, 3: 1096-1101.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2499_CR32","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/bmj.320.7235.611","volume":"320","author":"JHC Tosswill","year":"2000","unstructured":"Tosswill JHC, Taylor GP, Tedder RS, Mortimer PP, Voss LD, Mulligan J: HTLV-I\/II associated disease in England and Wales, 1993\u20137: retrospective review of serology requests. Br Med J 2000, 320: 611-612. 10.1136\/bmj.320.7235.611","journal-title":"Br Med J"},{"key":"2499_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00251-005-0048-3","volume":"57","author":"Y Itoh","year":"2005","unstructured":"Itoh Y, Mizuki N, Shimada T, Azuma F, Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M, Inoko H: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005, 57: 717-729. 10.1007\/s00251-005-0048-3","journal-title":"Immunogenetics"},{"key":"2499_CR34","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1099\/vir.0.010199-0","volume":"90","author":"K Suemori","year":"2009","unstructured":"Suemori K, Fujiwara H, Ochi T, Ogawa T, Matsuoka M, Matsumoto T, Mesnard J-M, Yasukawa M: HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol 2009, 90: 1806-1811. 10.1099\/vir.0.010199-0","journal-title":"J Gen Virol"},{"key":"2499_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/infdis\/jiq078","volume":"203","author":"S Hilburn","year":"2011","unstructured":"Hilburn S, Rowan A, Demontis M-A, MacNamara A, Asquith B, Bangham CRM, Taylor GP: In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis 2011, 203: 529-536. 10.1093\/infdis\/jiq078","journal-title":"J Infect Dis"},{"key":"2499_CR36","doi-asserted-by":"publisher","first-page":"D493","DOI":"10.1093\/nar\/gkh103","volume":"32","author":"D Karolchik","year":"2004","unstructured":"Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ: The UCSC Table Browser data retrieval tool. Nucleic Acids Res 2004, 32: D493-D496. 10.1093\/nar\/gkh103","journal-title":"Nucleic Acids Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-11-172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:00:43Z","timestamp":1630562443000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-11-172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2499"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-11-172","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]},"assertion":[{"value":"11 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"172"}}